American Bio Medica Corp (ABMC)

[AdamS007]

Hi Tyler, welcome to the board my friend....very respectful questions you pose and will be happy to take the time to answer them...I will copy and then answer your posts...as I am very "well off" in the knowledge of this equity...

Hello there,

Excited to join this message board after finding it on Twitter. I got in on ABMC at $.85 last week, and I'm still debating whether to take a much larger position. From reading all of your posts, you would think it's preposterous to not load up on every ABMC share possible.

I have some hesitations, and I think it's healthy to have someone playing devil's advocate here.

First of all, Stuart Sternberg isn't a billionaire — net worth is 800M. Still very wealthy, but you all keep calling him a billionaire, and that's an exaggeration. - Yes, Celebrity Net worth 800M, but we know its more than what they see/report, and HIS team according to Yahoo Finance is worth: $1.01 billion

https://finance.yahoo.com/news/20-richest-mlb-team-owners-090000929.html

Second, we don't know for certain that there is a 43% profit "on every test". We are basing this off of Melissa's statement where she said the revenues "resulted in approximately $430,000 in profit". I understand the sentiment that this bodes well for investors, but to say that is the profit margin on every test is, again, and exaggeration.

Yes it is 43% avg on every test...please consider this, that the BULK orders to Govt Entities and the Highest of Orders get it for $5 per test, so, in turn, if you averaged it out where tests in lower amount of orders range from $10-$35 (Int'l) per test, the Margin would be substantially HIGHER if this were averaged out per test instead or orders as such. Proof of just Florida https://www.fafcc.org/page/ImportantCoronavirusInformationForFAFCCMembers

Another concern I have is the leadership team's desire to issue a press release that highlights the company's accomplishments. From what I understand, they put themselves at risk with the SEC by putting out a press release — I'm not sure I buy that. CODX certainly did not have any problem communicating to the public the benchmarks they achieved in regards to their COVID-tests. I have real concern about anybody finding out about ABMC because of Melissa's reluctance to ever issue PR. Please understand that this year the SEC has established an SEC Covid Police team that have suspended at least 14 Tickers such as DECN, PRED and others for PUMPING CV items. This company does not pump, and most would consider that a good thing. When they return to "current" in the next week, as the auditors where Pandemically backlogged due to being in NYC, we, through communication via emails with the CEO, have been told they would be forthcoming.

And that ties into another concern I have, which is the lackluster performance of ABMC over the last 10+ years. I understand they have never been in a position to achieve the kind of revenue and profits that they currently can (potentially) with their new COVID-test. But this leadership team — despite being at the helm for decades — has kept this stock middling in mediocrity for the duration its tenure. You answered your own question here...ABMC Right Place Right Time, 2 decade long relationship through Healgen, the maker of the test. You see, the reason why the profit margins are so high, is bc they are a distributor, and they get the test in, QC and wrap in ABMC packaging and out they go.
You can NOT buy from Healgen and they have the entire eastern seaboard including the state of Louisiana as you will read the $190M CV Test Deal

While the pivot to distribute a COVID-test during a time when their main line of products was negatively impacted was a very prudent move, I question whether Melissa and team have what it takes to reward shareholders by issuing some much needed PR. 10Q drops, Yield to GO, PRs will be coming...double back this time next week

I am concerned that even if/when ABMC reveals exciting revenues, that still nobody will know about this company and we will keep telling ourselves that big news is coming, but in reality, it's an OTC stock that has — for 30 years — been trading for pennies, with the same leadership that we have today. Pandemically Perfect Timing as indicated earlier.

Curious what all of your thoughts are regarding these concerns.